SCHEMBL10071090

SCHEMBL10071090

C[C@@H](Cc1ccc(OCc2ccccc2)cc1)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.67
PPARA Q07869 4/20 0.65
PPARG P37231 4/20 0.65
MAOB P27338 2/20 0.63
PPARD Q03181 1/20 0.61
FFAR4 Q5NUL3 1/20 0.60
LTA4H P09960 2/20 0.58
MME P08473 1/20 0.57
ACE P12821 1/20 0.57
CPA1 P15085 1/20 0.57
ACE2 Q9BYF1 1/20 0.57
LAP3 P28838 1/20 0.57
NR4A1 P22736 1/20 0.57
NR4A2 P43354 1/20 0.57
NR4A3 Q92570 1/20 0.57
ALOX5 P09917 3/20 0.56
LMNA P02545 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
PTGS1 P23219 1/20 0.55
PTGS2 P35354 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4665082 1.00 FFAR1 (0.67) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL14501342 0.89 MAOB (0.61) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL14501338 0.89 MAOB (0.61) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL25901508 0.88 LTA4H (0.65) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL11445970 0.88 MAOB (0.60) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL21366441 0.87 LTA4H (0.68) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL27977003 0.87 LTA4H (0.68) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL8416496 0.87 MAOB (0.59) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL7801265 0.85 PPARA (0.70) FFAR1PPARAPPARGMAOBPPARD
SCHEMBL6029226 0.85 FFAR1 (0.67) FFAR1MAOBFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023025861-A1 NEW VASHS INHIBITORS, CONJUGATES THEREOF AND THEIR USES AS DRUGS OR AS RESEARCH TOOLS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2023-03-02 WO disclosed
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS BRACCO IMAGING SPA (IT) 2012-02-23 US disclosed
US-7223881-B2 Process for the preparation of new antidiabetic agents DR. REDDY'S LABORATORIES LIMITED (IN) 2007-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120045393-A1 LHRH-II PEPTIDE ANALOGS LHCGR, GNRHR, FSHR FFAR1 395/4885PPARA 2409/4885PPARG 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.